Recombinant human interferon β1b (Beijing Jinsaishi)
重组人干扰素β1b（北京金赛狮）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human interferon β1b (Beijing Jinsaishi)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesBeijing Jinsaishi Biopharmaceutical Technology Development Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBeijing Jinsaishi Biopharmaceutical Technology Development Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A